Entering text into the input field will update the search result below

Nivalis exploring strategic alternatives; shares perk up 7% premarket

Jan. 04, 2017 9:03 AM ETAlpine Immune Sciences, Inc. (ALPN) StockBy: Douglas W. House, SA News Editor
  • Thinly traded nano cap Nivalis Therapeutics (NVLS) is up 7% premarket on increased volume. After the close yesterday, it announced that the board has initiated a process to "explore and review a range of strategic alternatives" to boost shareholder value.
  • Ladenburg Thalmann is advising.

Recommended For You

More Trending News

About ALPN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ALPN--
Alpine Immune Sciences, Inc.